# Clinical Study of Glaukos® Trabecular Micro-Bypass System Model iS3 Infinite Vs. Competitor

> **NCT05127551** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Glaukos Corporation** · enrollment: 179 (actual)

## Conditions studied

- Glaucoma
- Glaucoma, Open-Angle

## Interventions

- **DEVICE:** iStent Infinite
- **DEVICE:** Competitor Device

## Key facts

- **NCT ID:** NCT05127551
- **Lead sponsor:** Glaukos Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-11-27
- **Primary completion:** 2024-02-29
- **Final completion:** 2025-02-28
- **Target enrollment:** 179 (ACTUAL)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05127551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05127551, "Clinical Study of Glaukos® Trabecular Micro-Bypass System Model iS3 Infinite Vs. Competitor". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05127551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*